Table of Contents 1 Meningococcal Group B Vaccine Market Overview 1.1 Product Overview and Scope of Meningococcal Group B Vaccine 1.2 Meningococcal Group B Vaccine Segment by Type 1.2.1 Global Meningococcal Group B Vaccine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Type 1 1.2.3 Type 2 1.3 Meningococcal Group B Vaccine Segment by Application 1.3.1 Meningococcal Group B Vaccine Sales Comparison by Application: 2020 VS 2026 1.3.2 Public 1.3.3 Private 1.4 Global Meningococcal Group B Vaccine Market Size Estimates and Forecasts 1.4.1 Global Meningococcal Group B Vaccine Revenue 2015-2026 1.4.2 Global Meningococcal Group B Vaccine Sales 2015-2026 1.4.3 Meningococcal Group B Vaccine Market Size by Region: 2020 Versus 2026 2 Global Meningococcal Group B Vaccine Market Competition by Manufacturers 2.1 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2015-2020) 2.2 Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2015-2020) 2.3 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Meningococcal Group B Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Meningococcal Group B Vaccine Market Competitive Situation and Trends 2.5.1 Meningococcal Group B Vaccine Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Meningococcal Group B Vaccine Players (Opinion Leaders) 3 Meningococcal Group B Vaccine Retrospective Market Scenario by Region 3.1 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Meningococcal Group B Vaccine Market Facts & Figures by Country 3.3.1 North America Meningococcal Group B Vaccine Sales by Country 3.3.2 North America Meningococcal Group B Vaccine Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Meningococcal Group B Vaccine Market Facts & Figures by Country 3.4.1 Europe Meningococcal Group B Vaccine Sales by Country 3.4.2 Europe Meningococcal Group B Vaccine Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region 3.5.2 Asia Pacific Meningococcal Group B Vaccine Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Meningococcal Group B Vaccine Market Facts & Figures by Country 3.6.1 Latin America Meningococcal Group B Vaccine Sales by Country 3.6.2 Latin America Meningococcal Group B Vaccine Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Country 3.7.2 Middle East and Africa Meningococcal Group B Vaccine Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Meningococcal Group B Vaccine Historic Market Analysis by Type 4.1 Global Meningococcal Group B Vaccine Sales Market Share by Type (2015-2020) 4.2 Global Meningococcal Group B Vaccine Revenue Market Share by Type (2015-2020) 4.3 Global Meningococcal Group B Vaccine Price Market Share by Type (2015-2020) 4.4 Global Meningococcal Group B Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Meningococcal Group B Vaccine Historic Market Analysis by Application 5.1 Global Meningococcal Group B Vaccine Sales Market Share by Application (2015-2020) 5.2 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2015-2020) 5.3 Global Meningococcal Group B Vaccine Price by Application (2015-2020) 6 Company Profiles and Key Figures in Meningococcal Group B Vaccine Business 6.1 GSK 6.1.1 Corporation Information 6.1.2 GSK Description, Business Overview and Total Revenue 6.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.1.4 GSK Products Offered 6.1.5 GSK Recent Development 6.2 Pfizer 6.2.1 Pfizer Meningococcal Group B Vaccine Production Sites and Area Served 6.2.2 Pfizer Description, Business Overview and Total Revenue 6.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Pfizer Products Offered 6.2.5 Pfizer Recent Development 7 Meningococcal Group B Vaccine Manufacturing Cost Analysis 7.1 Meningococcal Group B Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Meningococcal Group B Vaccine 7.4 Meningococcal Group B Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Meningococcal Group B Vaccine Distributors List 8.3 Meningococcal Group B Vaccine Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Meningococcal Group B Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Type (2021-2026) 10.2 Meningococcal Group B Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Application (2021-2026) 10.3 Meningococcal Group B Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Region (2021-2026) 10.4 North America Meningococcal Group B Vaccine Estimates and Projections (2021-2026) 10.5 Europe Meningococcal Group B Vaccine Estimates and Projections (2021-2026) 10.6 Asia Pacific Meningococcal Group B Vaccine Estimates and Projections (2021-2026) 10.7 Latin America Meningococcal Group B Vaccine Estimates and Projections (2021-2026) 10.8 Middle East and Africa Meningococcal Group B Vaccine Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Meningococcal Group B Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Meningococcal Group B Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Meningococcal Group B Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Meningococcal Group B Vaccine Manufacturers Covered in This Study Table 5. Global Meningococcal Group B Vaccine Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Meningococcal Group B Vaccine Sales Share by Manufacturers (2015-2020) Table 7. Global Meningococcal Group B Vaccine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Meningococcal Group B Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Meningococcal Group B Vaccine Sales Sites and Area Served Table 11. Manufacturers Meningococcal Group B Vaccine Product Types Table 12. Global Meningococcal Group B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Group B Vaccine as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Meningococcal Group B Vaccine Players Table 16. Global Meningococcal Group B Vaccine Sales (K Units) by Region (2015-2020) Table 17. Global Meningococcal Group B Vaccine Sales Market Share by Region (2015-2020) Table 18. Global Meningococcal Group B Vaccine Revenue (Million US$) by Region (2015-2020) Table 19. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2015-2020) Table 20. North America Meningococcal Group B Vaccine Sales by Country (2015-2020) (K Units) Table 21. North America Meningococcal Group B Vaccine Sales Market Share by Country (2015-2020) Table 22. North America Meningococcal Group B Vaccine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Meningococcal Group B Vaccine Revenue Market Share by Country (2015-2020) Table 24. Europe Meningococcal Group B Vaccine Sales by Country (2015-2020) (K Units) Table 25. Europe Meningococcal Group B Vaccine Sales Market Share by Country (2015-2020) Table 26. Europe Meningococcal Group B Vaccine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Meningococcal Group B Vaccine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region (2015-2020) Table 32. Latin America Meningococcal Group B Vaccine Sales by Country (2015-2020) (K Units) Table 33. Latin America Meningococcal Group B Vaccine Sales Market Share by Country (2015-2020) Table 34. Latin America Meningococcal Group B Vaccine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country (2015-2020) Table 40. Global Meningococcal Group B Vaccine Sales (K Units) by Type (2015-2020) Table 41. Global Meningococcal Group B Vaccine Sales Share by Type (2015-2020) Table 42. Global Meningococcal Group B Vaccine Revenue (Million US$) by Type (2015-2020) Table 43. Global Meningococcal Group B Vaccine Revenue Share by Type (2015-2020) Table 44. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2015-2020) Table 45. Global Meningococcal Group B Vaccine Sales (K Units) by Application (2015-2020) Table 46. Global Meningococcal Group B Vaccine Sales Market Share by Application (2015-2020) Table 47. Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2015-2020) Table 48. GSK Meningococcal Group B Vaccine Corporation Information Table 49. GSK Description and Business Overview Table 50. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. GSK Main Product Table 52. GSK Recent Development Table 53. Pfizer Meningococcal Group B Vaccine Corporation Information Table 54. Pfizer Corporation Information Table 55. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Pfizer Main Product Table 57. Pfizer Recent Development Table 58. Sales Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Meningococcal Group B Vaccine Distributors List Table 61. Meningococcal Group B Vaccine Customers List Table 62. Market Key Trends Table 63. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 64. Key Challenges Table 65. Global Meningococcal Group B Vaccine Sales (K Units) Forecast by Type (2021-2026) Table 66. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Type (2021-2026) Table 67. Global Meningococcal Group B Vaccine Revenue (Million US$) Forecast by Type (2021-2026) Table 68. Global Meningococcal Group B Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 69. Global Meningococcal Group B Vaccine Sales (K Units) Forecast by Application (2021-2026) Table 70. Global Meningococcal Group B Vaccine Revenue (Million US$) Forecast by Application (2021-2026) Table 71. Global Meningococcal Group B Vaccine Sales (K Units) Forecast by Region (2021-2026) Table 72. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Region (2021-2026) Table 73. Global Meningococcal Group B Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 74. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Meningococcal Group B Vaccine Figure 2. Global Meningococcal Group B Vaccine Sales Market Share by Type: 2020 VS 2026 Figure 3. Type 1 Product Picture Figure 4. Type 2 Product Picture Figure 5. Global Meningococcal Group B Vaccine Consumption Market Share by Application: 2020 VS 2026 Figure 6. Public Figure 7. Private Figure 8. Global Meningococcal Group B Vaccine Market Size 2015-2026 (US$ Million) Figure 9. Global Meningococcal Group B Vaccine Sales Capacity (K Units) (2015-2026) Figure 10. Global Meningococcal Group B Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Meningococcal Group B Vaccine Sales Share by Manufacturers in 2020 Figure 12. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Meningococcal Group B Vaccine Revenue in 2019 Figure 14. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Meningococcal Group B Vaccine Sales Market Share by Region (2015-2020) Figure 16. Global Meningococcal Group B Vaccine Sales Market Share by Region in 2019 Figure 17. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2015-2020) Figure 18. Global Meningococcal Group B Vaccine Revenue Market Share by Region in 2019 Figure 19. North America Meningococcal Group B Vaccine Sales Market Share by Country in 2019 Figure 20. North America Meningococcal Group B Vaccine Revenue Market Share by Country in 2019 Figure 21. U.S. Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 22. U.S. Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Meningococcal Group B Vaccine Sales Market Share by Country in 2019 Figure 26. Europe Meningococcal Group B Vaccine Revenue Market Share by Country in 2019 Figure 27. Germany Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 30. France Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 32. U.K. Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region in 2019 Figure 38. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region in 2019 Figure 39. China Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 40. China Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 46. India Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Meningococcal Group B Vaccine Sales Market Share by Country in 2019 Figure 62. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country in 2019 Figure 63. Mexico Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country in 2019 Figure 71. Turkey Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Meningococcal Group B Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 76. U.A.E Meningococcal Group B Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Meningococcal Group B Vaccine by Type (2015-2020) Figure 78. Sales Market Share of Meningococcal Group B Vaccine by Type in 2019 Figure 79. Revenue Share of Meningococcal Group B Vaccine by Type (2015-2020) Figure 80. Revenue Market Share of Meningococcal Group B Vaccine by Type in 2019 Figure 81. Global Meningococcal Group B Vaccine Sales Growth by Type (2015-2020) (K Units) Figure 82. Global Meningococcal Group B Vaccine Sales Market Share by Application (2015-2020) Figure 83. Global Meningococcal Group B Vaccine Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Meningococcal Group B Vaccine by Application (2015-2020) Figure 85. Global Revenue Share of Meningococcal Group B Vaccine by Application in 2020 Figure 86. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Price Trend of Key Raw Materials Figure 89. Manufacturing Cost Structure of Meningococcal Group B Vaccine Figure 90. Manufacturing Process Analysis of Meningococcal Group B Vaccine Figure 91. Meningococcal Group B Vaccine Industrial Chain Analysis Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Porter's Five Forces Analysis Figure 95. North America Meningococcal Group B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 96. North America Meningococcal Group B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 97. Europe Meningococcal Group B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 98. Europe Meningococcal Group B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 99. Latin America Meningococcal Group B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 100. Latin America Meningococcal Group B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 101. Middle East and Africa Meningococcal Group B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 102. Middle East and Africa Meningococcal Group B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Asia Pacific Meningococcal Group B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 104. Asia Pacific Meningococcal Group B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Bottom-up and Top-down Approaches for This Report Figure 106. Data Triangulation Figure 107. Key Executives Interviewed

GSK Pfizer